STEPHANIE CANALES: Open Payments
NPI 1639916851 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 30 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $284 · 2025 $957
Food & beverage: $858Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $251 |
| Janssen Biotech, Inc. | 4 | $174 |
| Daiichi Sankyo Inc. | 5 | $134 |
| Novartis Pharmaceuticals Corporation | 4 | $106 |
| Adaptive Biotechnologies Corporation | 3 | $93 |
| SOBI, INC | 2 | $59 |
| Incyte Corporation | 2 | $40 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
| Fresenius Kabi USA, LLC | 1 | $27 |
| BeOne Medicines USA, Inc. | 1 | $20 |
Products named: Vanflyta, BOTOX, DARZALEX, SCEMBLIX, clonoSEQ, EPKINLY, Vonjo, TALVEY.
Industry payments across TX — which companies pay providers there.
